Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead [correspondence]

J van Griensven; L Lynen; R Colebunders

doi:10.1097/QAD.0b013e328329d04b

Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead [correspondence]

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	AIDS
Volume	23
Issue number	8
Pages (from-to)	1027
ISSN	0269-9370
DOIs	https://doi.org/10.1097/QAD.0b013e328329d04b
Publication status	Published - 2009

Keywords

B780-tropical-medicine
Viral diseases
HIV
AIDS
Drug therapy
Antiretrovirals
First-line drugs
Second-line drugs
Regimens
Tenofovir
Stavudine
Toxicity
Adverse effects
Drug resistance
Developing countries

Access to Document

10.1097/QAD.0b013e328329d04b

http://lib.itg.be/pdf/itg/2009/2009aids1027.pdf

Cite this

@article{fe3d0835c031459cb08d79edde5ce326,

title = "Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead [correspondence]",

keywords = "B780-tropical-medicine, Viral diseases, HIV, AIDS, Drug therapy, Antiretrovirals, First-line drugs, Second-line drugs, Regimens, Tenofovir, Stavudine, Toxicity, Adverse effects, Drug resistance, Developing countries",

author = "{van Griensven}, J and L Lynen and R Colebunders",

note = "ITG-C1B; ITG-C2A; ITG-CLA; CLINIC; U-HIVCLI; JIF; DOI; PDF; DSPACE",

year = "2009",

doi = "10.1097/QAD.0b013e328329d04b",

language = "English",

volume = "23",

pages = "1027",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams & Wilkins",

number = "8",

}

TY - JOUR

T1 - Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead [correspondence]

AU - van Griensven, J

AU - Lynen, L

AU - Colebunders, R

N1 - ITG-C1B; ITG-C2A; ITG-CLA; CLINIC; U-HIVCLI; JIF; DOI; PDF; DSPACE

PY - 2009

Y1 - 2009

KW - B780-tropical-medicine

KW - Viral diseases

KW - HIV

KW - AIDS

KW - Drug therapy

KW - Antiretrovirals

KW - First-line drugs

KW - Second-line drugs

KW - Regimens

KW - Tenofovir

KW - Stavudine

KW - Toxicity

KW - Adverse effects

KW - Drug resistance

KW - Developing countries

U2 - 10.1097/QAD.0b013e328329d04b

DO - 10.1097/QAD.0b013e328329d04b

M3 - Letter

SN - 0269-9370

VL - 23

SP - 1027

JO - AIDS

JF - AIDS

IS - 8

ER -